Bimekizumab Efficacy and Safety Over 48 Weeks in US and Canadian Patients With Psoriasis Who Had a Treatment Interruption After 3 Years of Treatment: Results from BE RADIANT. J of Skin 2024, 8 (6), s431. https://doi.org/10.25251/skin.8.supp.431.